Health
Sacubitril/Valsartan Treatment for HFpEF Shown to Reduce NT-proBNP Levels – AJMC.com Managed Markets Network
Wanting more data on the benefits of sacubitril/valsartan vs renin angiotensin system inhibitor background therapy, investigators…
Among several measures evaluated in a 24-week, randomized, double-blind, parallel group clinical trial comparing outcomes among patients with heart failure with preserved ejection fraction (HFpEF; left ventricular ejection fraction > 40%), sacubitril/valsartan…
Continue Reading
-
Noosa News10 hours agoChild, 15, arrested over death of another child, 8, after shocking e-bike crash in Queensland
-
Noosa News15 hours agoLarge fleet of Robinson R22 helicopters sold as HM Air flies in another direction
-
General7 hours agoCrowe toasts talkback titan for platforming ‘voiceless’
-
Noosa News9 hours agoLyka Doggie Date Night at Moonlight Cinema